Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	343.67	828.69	840.3	1,163	996.15	1,408
Short-Term Investments	61.68	62.86	623.04	200.26	-	-
Trading Asset Securities	1,262	1,306	722.45	938.07	572.73	102.6
Cash & Short-Term Investments	1,667	2,198	2,186	2,301	1,569	1,511
Cash Growth	-27.62%	0.55%	-5.00%	46.66%	3.84%	54.09%
Accounts Receivable	1,224	1,130	599.87	540.97	501.78	269.93
Other Receivables	78.78	44.25	51.72	66.6	64.7	68.38
Receivables	1,303	1,174	651.59	607.57	566.48	338.31
Inventory	347.36	359.56	351.4	399.97	386.24	376.66
Other Current Assets	66.26	54.17	44.57	42	63.9	44.41
Total Current Assets	3,383	3,786	3,233	3,350	2,586	2,270
Property, Plant & Equipment	1,475	1,484	1,353	1,189	906.09	676.63
Long-Term Investments	1,540	1,391	709.48	1,284	971.42	1,025
Goodwill	111.42	111.42	111.42	115.37	42.51	48.39
Other Intangible Assets	224.12	205.51	194.52	203.71	208.11	180.19
Long-Term Deferred Tax Assets	74.31	76.18	57.47	53.86	42.77	24.45
Long-Term Deferred Charges	77.25	56.46	80.03	65.04	69.76	59.48
Other Long-Term Assets	15.42	44.59	32.83	39.41	29.66	21.33
Total Assets	6,900	7,155	5,772	6,301	4,856	4,306
Accounts Payable	271.17	288.37	130.46	320.08	399.99	299.51
Accrued Expenses	82.78	201.41	193.5	229.74	184.01	190.59
Short-Term Debt	1.71	14.85	4.26	208.42	19.14	101
Current Portion of Long-Term Debt	-	-	-	-	12.53	9.07
Current Portion of Leases	5.37	5.41	19.01	16.86	28.24	-
Current Income Taxes Payable	6.87	42.6	21.84	58.73	4.69	52.69
Current Unearned Revenue	64.94	77.1	72.88	236.31	80.55	97.68
Other Current Liabilities	158.94	191.73	42.29	70.91	62.4	42.9
Total Current Liabilities	591.78	821.46	484.23	1,141	791.54	793.45
Long-Term Debt	584.93	570.97	552.84	532.49	510.69	501.03
Long-Term Leases	11.29	14.33	27.69	11.19	10.42	0.78
Long-Term Unearned Revenue	42.44	47.94	37.21	23.1	9.4	8.11
Long-Term Deferred Tax Liabilities	42.18	49.66	55.12	55.75	29.7	9.1
Total Liabilities	1,273	1,504	1,157	1,764	1,352	1,312
Common Stock	478.63	481.42	444.52	444.51	444.95	342.57
Additional Paid-In Capital	1,426	1,458	765.52	775.53	787.01	866
Retained Earnings	3,804	3,807	3,433	3,166	2,101	1,637
Treasury Stock	-135.76	-171.02	-132.46	-157.3	-139.25	-127.56
Comprehensive Income & Other	-21.33	-21.29	5.9	115.39	159.18	123.98
Total Common Equity	5,551	5,554	4,516	4,344	3,353	2,842
Minority Interest	75.99	95.9	98.66	193.8	150.97	151.33
Shareholders' Equity	5,627	5,650	4,615	4,538	3,504	2,994
Total Liabilities & Equity	6,900	7,155	5,772	6,301	4,856	4,306
Total Debt	603.3	605.57	603.8	768.96	581.01	611.89
Net Cash (Debt)	1,064	1,592	1,582	1,532	987.87	899.02
Net Cash Growth	-36.74%	0.65%	3.27%	55.07%	9.88%	-3.83%
Net Cash Per Share	2.22	3.43	3.57	3.47	2.23	2.04
Filing Date Shares Outstanding	485.29	477.87	440.96	441.26	444.95	445.34
Total Common Shares Outstanding	485.29	477.87	440.96	441.26	444.95	445.34
Working Capital	2,791	2,964	2,749	2,209	1,794	1,477
Book Value Per Share	11.44	11.62	10.24	9.84	7.54	6.38
Tangible Book Value	5,216	5,237	4,210	4,025	3,102	2,614
Tangible Book Value Per Share	10.75	10.96	9.55	9.12	6.97	5.87
Buildings	1,008	1,007	530.37	447.3	436.03	202.5
Machinery	1,117	1,071	1,021	940.43	741.37	575.35
Construction In Progress	9.47	5.12	290.84	199.14	16.38	156.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.